2023 Indonesian Guidelines for Heart Failure Treatment: Working Group on Heart Failure and Cardiometabolic Diseases, Indonesian Heart Association
Heart failure is a health problem with high mortality and morbidity rates in developed and developing countries such as Indonesia. The prevalence of heart failure itself is increasing because patients who experience acute heart failure can progress to chronic heart failure. Guidelines-Directed Medi...
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Indonesian Heart Association
2025-01-01
|
Series: | Majalah Kardiologi Indonesia |
Subjects: | |
Online Access: | https://ijconline.id/index.php/ijc/article/view/1671 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841546542686666752 |
---|---|
author | Dian Yaniarti Hasanah, MD Edrian - Zulkarnain, MD Habibie - Arifianto, MD Hawani Sasmaya Prameswari, MD Leonardo Paskah Suciadi, MD Paskariatne Probo Dewi Yamin, MD Rarsari Soerarso Pratikno, MD Siti Elkana Nauli, MD Vebiona Kartini Prima Putri, MD Wahyu Aditya Soedarsono, MD Yuke - Sarastri, MD |
author_facet | Dian Yaniarti Hasanah, MD Edrian - Zulkarnain, MD Habibie - Arifianto, MD Hawani Sasmaya Prameswari, MD Leonardo Paskah Suciadi, MD Paskariatne Probo Dewi Yamin, MD Rarsari Soerarso Pratikno, MD Siti Elkana Nauli, MD Vebiona Kartini Prima Putri, MD Wahyu Aditya Soedarsono, MD Yuke - Sarastri, MD |
author_sort | Dian Yaniarti Hasanah, MD |
collection | DOAJ |
description |
Heart failure is a health problem with high mortality and morbidity rates in developed and developing countries such as Indonesia. The prevalence of heart failure itself is increasing because patients who experience acute heart failure can progress to chronic heart failure. Guidelines-Directed Medical Therapy (GDMT) with recommended doses is still underutilized in heart failure patients with reduced ejection fraction (HFrEF). In Indonesia itself, even though it has a fairly high rate of use of ACE-inhibitors (ACE-I) or angiotensin receptor blockers (ARB), Indonesia has the lowest rate of use of β-blockers and aldosterone inhibitors (also called Mineralocorticoid Receptor Antagonists, MRA) of the entire ASIAN-HF registry.84
Therefore, the writing of this guideline was carried out as an effort to provide practical guidance regarding the diagnosis, assessment and management of acute and chronic heart failure. Thus, it is hoped that efforts can be made to prevent the increase in prevalence and reduce the number of rehospitalization with complete management.
This book was written as an update to the 2020 Guideline for the Management of Heart Failure: Indonesian Heart Association. The sources of our updates came from many references and literatures carried out by each contributor and reviewed by EBM team.
|
format | Article |
id | doaj-art-e9d1a5ca25e64670b8b565528eca5aad |
institution | Kabale University |
issn | 0126-3773 2620-4762 |
language | English |
publishDate | 2025-01-01 |
publisher | Indonesian Heart Association |
record_format | Article |
series | Majalah Kardiologi Indonesia |
spelling | doaj-art-e9d1a5ca25e64670b8b565528eca5aad2025-01-10T16:38:15ZengIndonesian Heart AssociationMajalah Kardiologi Indonesia0126-37732620-47622025-01-0145210.30701/ijc.16712023 Indonesian Guidelines for Heart Failure Treatment: Working Group on Heart Failure and Cardiometabolic Diseases, Indonesian Heart AssociationDian Yaniarti Hasanah, MD0Edrian - Zulkarnain, MD1Habibie - Arifianto, MD2Hawani Sasmaya Prameswari, MD3Leonardo Paskah Suciadi, MD4Paskariatne Probo Dewi Yamin, MD5Rarsari Soerarso Pratikno, MD6Siti Elkana Nauli, MD7Vebiona Kartini Prima Putri, MD8Wahyu Aditya Soedarsono, MD9Yuke - Sarastri, MD10National Cardiovascular Center Harapan Kita, JakartaMohammad Hoesin General Hospital, PalembangUniversitas Sebelas Maret Academic Hospital, Surakartadr. Hasan Sadikin General Hospital, BandungSiloam Hospitals Kebon Jeruk, JakartaGatot Soebroto Central Army Hospital, JakartaNational Cardiovascular Center Harapan Kita, JakartaTangerang District HospitalAwal Bros Hospital, PekanbaruGatot Soebroto Central Army Hospital, JakartaHj. Adam Malik General Hospital, Medan Heart failure is a health problem with high mortality and morbidity rates in developed and developing countries such as Indonesia. The prevalence of heart failure itself is increasing because patients who experience acute heart failure can progress to chronic heart failure. Guidelines-Directed Medical Therapy (GDMT) with recommended doses is still underutilized in heart failure patients with reduced ejection fraction (HFrEF). In Indonesia itself, even though it has a fairly high rate of use of ACE-inhibitors (ACE-I) or angiotensin receptor blockers (ARB), Indonesia has the lowest rate of use of β-blockers and aldosterone inhibitors (also called Mineralocorticoid Receptor Antagonists, MRA) of the entire ASIAN-HF registry.84 Therefore, the writing of this guideline was carried out as an effort to provide practical guidance regarding the diagnosis, assessment and management of acute and chronic heart failure. Thus, it is hoped that efforts can be made to prevent the increase in prevalence and reduce the number of rehospitalization with complete management. This book was written as an update to the 2020 Guideline for the Management of Heart Failure: Indonesian Heart Association. The sources of our updates came from many references and literatures carried out by each contributor and reviewed by EBM team. https://ijconline.id/index.php/ijc/article/view/1671Heart failureManagementGuidelineIndonesia |
spellingShingle | Dian Yaniarti Hasanah, MD Edrian - Zulkarnain, MD Habibie - Arifianto, MD Hawani Sasmaya Prameswari, MD Leonardo Paskah Suciadi, MD Paskariatne Probo Dewi Yamin, MD Rarsari Soerarso Pratikno, MD Siti Elkana Nauli, MD Vebiona Kartini Prima Putri, MD Wahyu Aditya Soedarsono, MD Yuke - Sarastri, MD 2023 Indonesian Guidelines for Heart Failure Treatment: Working Group on Heart Failure and Cardiometabolic Diseases, Indonesian Heart Association Majalah Kardiologi Indonesia Heart failure Management Guideline Indonesia |
title | 2023 Indonesian Guidelines for Heart Failure Treatment: Working Group on Heart Failure and Cardiometabolic Diseases, Indonesian Heart Association |
title_full | 2023 Indonesian Guidelines for Heart Failure Treatment: Working Group on Heart Failure and Cardiometabolic Diseases, Indonesian Heart Association |
title_fullStr | 2023 Indonesian Guidelines for Heart Failure Treatment: Working Group on Heart Failure and Cardiometabolic Diseases, Indonesian Heart Association |
title_full_unstemmed | 2023 Indonesian Guidelines for Heart Failure Treatment: Working Group on Heart Failure and Cardiometabolic Diseases, Indonesian Heart Association |
title_short | 2023 Indonesian Guidelines for Heart Failure Treatment: Working Group on Heart Failure and Cardiometabolic Diseases, Indonesian Heart Association |
title_sort | 2023 indonesian guidelines for heart failure treatment working group on heart failure and cardiometabolic diseases indonesian heart association |
topic | Heart failure Management Guideline Indonesia |
url | https://ijconline.id/index.php/ijc/article/view/1671 |
work_keys_str_mv | AT dianyaniartihasanahmd 2023indonesianguidelinesforheartfailuretreatmentworkinggrouponheartfailureandcardiometabolicdiseasesindonesianheartassociation AT edrianzulkarnainmd 2023indonesianguidelinesforheartfailuretreatmentworkinggrouponheartfailureandcardiometabolicdiseasesindonesianheartassociation AT habibiearifiantomd 2023indonesianguidelinesforheartfailuretreatmentworkinggrouponheartfailureandcardiometabolicdiseasesindonesianheartassociation AT hawanisasmayaprameswarimd 2023indonesianguidelinesforheartfailuretreatmentworkinggrouponheartfailureandcardiometabolicdiseasesindonesianheartassociation AT leonardopaskahsuciadimd 2023indonesianguidelinesforheartfailuretreatmentworkinggrouponheartfailureandcardiometabolicdiseasesindonesianheartassociation AT paskariatneprobodewiyaminmd 2023indonesianguidelinesforheartfailuretreatmentworkinggrouponheartfailureandcardiometabolicdiseasesindonesianheartassociation AT rarsarisoerarsopratiknomd 2023indonesianguidelinesforheartfailuretreatmentworkinggrouponheartfailureandcardiometabolicdiseasesindonesianheartassociation AT sitielkananaulimd 2023indonesianguidelinesforheartfailuretreatmentworkinggrouponheartfailureandcardiometabolicdiseasesindonesianheartassociation AT vebionakartiniprimaputrimd 2023indonesianguidelinesforheartfailuretreatmentworkinggrouponheartfailureandcardiometabolicdiseasesindonesianheartassociation AT wahyuadityasoedarsonomd 2023indonesianguidelinesforheartfailuretreatmentworkinggrouponheartfailureandcardiometabolicdiseasesindonesianheartassociation AT yukesarastrimd 2023indonesianguidelinesforheartfailuretreatmentworkinggrouponheartfailureandcardiometabolicdiseasesindonesianheartassociation |